会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明授权
    • Methods for diagnosis of allergy
    • 过敏诊断方法
    • US5714338A
    • 1998-02-03
    • US393014
    • 1995-02-27
    • David Tai Wai FeiJohn LowePaula Jardieu
    • David Tai Wai FeiJohn LowePaula Jardieu
    • G01N33/53G01N33/50G01N33/569G01N33/68C07K16/44C12N5/16G01N33/566
    • G01N33/6857G01N33/5047G01N33/56972G01N33/6854
    • Provided are methods for the diagnosis of allergic disease wherein IgE specific for an allergen of interest is detected in a patient serum sample by using the patient serum sample to sensitize in the presence or absence of an IgE antagonist a mast cell or basophil host genetically engineered to display surface expression of a Fc.epsilon.RI subunit that is capable of mediating the host cells release of a pharmacological mediator upon induction with patient serum and allergen, challenging the sensitized host cells with the allergen of interest, and determining the presence or absence of IgE specific to the allergen of interest in the patient serum sample by comparing the release of the pharmacological mediator produced by host cells sensitized with patient serum in the presence of the IgE antagonist to the release of the pharmacological mediator produced by host cells sensitized with patient serum in the absence of the IgE antagonist.
    • PCT No.PCT / US94 / 14282 Sec。 371日期:1995年2月27日 102(e)1995年2月27日PCT 1994年12月9日PCT PCT。 公开号WO95 / 16203 日期1995年6月15日提供了用于诊断过敏性疾病的方法,其中通过使用患者血清样品在存在或不存在IgE拮抗剂的情况下在患者血清样品中检测到感兴趣的变应原的IgE, 遗传工程改造的嗜碱性粒细胞宿主,以显示FcεRI亚基的表达表达,其能够在用患者血清和变应原诱导时介导宿主细胞释放药理学介质,并利用感兴趣的变应原对致敏宿主细胞进行挑战,并确定存在 或不存在对患者血清样品中感兴趣的变应原特异性的IgE,通过比较由存在IgE拮抗剂的患者血清致敏的宿主细胞产生的药理学介质与由致敏的宿主细胞产生的药理学介质的释放相关的释放 在没有IgE拮抗剂的情况下患有血清。
    • 4. 发明申请
    • System, Methods, And Apparatus For Interactive Advertising
    • 互动广告的系统,方法和装置
    • US20080071620A1
    • 2008-03-20
    • US11857328
    • 2007-09-18
    • John Lowe
    • John Lowe
    • G06Q30/00
    • G06Q30/0625G06F17/3087G06Q30/02G06Q30/0256G06Q30/0277
    • The present invention relates to a system and methodology for searching and presenting merchant and advertised information to a user over a wide area network such as the Internet. The system and method actively links manufacturer and merchant information within a search query so as to enable a user to conduct more efficient searching when seeking products or services in a proximity or geographical area. This Abstract is provided for the sole purpose of complying with the Abstract requirement rules that allow a reader to quickly ascertain the subject matter of the disclosure contained herein. This Abstract is submitted with the explicit understanding that it will not be used to interpret or to limit the scope or the meaning of the claims.
    • 本发明涉及一种用于通过诸如因特网的广域网向用户搜索和呈现商户和通告信息的系统和方法。 系统和方法主动地将搜索查询中的制造商和商家信息链接起来,以便使用户能够在邻近或地理区域寻求产品或服务时进行更有效的搜索。 本摘要仅用于遵守允许读者快速确定本文所包含的披露的主题的抽象要求规则。 本摘要以明确的理解提交,不会用于解释或限制权利要求的范围或含义。
    • 5. 发明申请
    • Attached personal information device
    • 附加个人信息设备
    • US20060059013A1
    • 2006-03-16
    • US10938503
    • 2004-09-13
    • John Lowe
    • John Lowe
    • G06Q50/00G06Q10/00
    • G06F19/323G06F19/00G06Q50/22G16H10/65
    • An information storage device may be semi-permanently attached to a wearer. The device can include an outer casing configured to be compatible with long term contact with a human body. A data storage component may store information of the wearer and a transceiver may wirelessly communicate information from the data storage component. The stored information can be, for example, the complete medical history of the wearer, “emergency” medical information, prescriptions, medical warnings (e.g., past history of coronary problems), financial information, social security numbers, or other useful information.
    • 信息存储装置可以半永久地附接到佩戴者。 该装置可以包括配置成与人体长期接触兼容的外壳。 数据存储部件可以存储佩戴者的信息,并且收发器可以从数据存储部件无线地传送信息。 存储的信息可以是例如佩戴者的完整病历,“紧急”医疗信息,处方,医疗警告(例如,冠状动脉问题的过去历史),财务信息,社会保险号码或其他有用信息。
    • 7. 发明授权
    • Anti-IgE antibodies
    • 抗IgE抗体
    • US06761889B2
    • 2004-07-13
    • US10113996
    • 2002-04-01
    • Henry B. LowmanLeonard G. PrestaPaula M. JardieuJohn Lowe
    • Henry B. LowmanLeonard G. PrestaPaula M. JardieuJohn Lowe
    • A61K39395
    • C07K16/00A61K38/00C07K16/4291C07K2317/24Y10S424/81Y10S530/868
    • The present invention relates to a method for adjusting the affinity of a polypeptide to a target molecule by a combination of steps, including: (1) the identification of aspartyl residues which are prone to isomerization; (2) the substitution of alternative residues and screening the resulting mutants for affinity against the target molecule. In a preferred embodiment, the method of subtituting residues is affinity maturation with phage display (AMPD). In a further preferred embodiment the polypeptide is an antibody and the target molecule is an antigen. In a further preferred embodiment, the antibody is anti-lgE and the target molecule is lgE. In another embodiment, the invention relates to an anti-IgE antibody having improved affinity to IgE.
    • 本发明涉及通过以下步骤的组合来调节多肽与靶分子的亲和力的方法,包括:(1)鉴定易于异构化的天冬氨酰残基; (2)替代替代残基并筛选得到的突变体对靶分子的亲合力。 在优选的实施方案中,残基残基的方法是用噬菌体展示(AMPD)进行亲和力成熟。 在另一优选实施方案中,多肽是抗体,靶分子是抗原。 在另一个优选的实施方案中,抗体是抗-IgE,靶分子是IgG。 在另一个实施方案中,本发明涉及对IgE具有改善的亲和力的抗IgE抗体。
    • 8. 发明授权
    • Anti-IgE antibodies
    • 抗IgE抗体
    • US06682735B2
    • 2004-01-27
    • US09920171
    • 2001-08-01
    • Henry B. LowmanLeonard G. PrestaPaula M. JardieuJohn Lowe
    • Henry B. LowmanLeonard G. PrestaPaula M. JardieuJohn Lowe
    • A61K39395
    • C07K16/00A61K38/00C07K16/4291C07K2317/24Y10S424/81Y10S530/868
    • The present invention relates to a method for adjusting the affinity of a polypeptide to a target molecule by a combination of steps, including: (1) the identification of aspartyl residues which are prone to isomerization; (2) the substitution of alternative residues and screening the resulting mutants for affinity against the target molecule. In a preferred embodiment, the method of subtituting residues is affinity maturation with phage display (AMPD). In a further preferred embodiment the polypeptide is an antibody and the target molecule is an antigen. In a further preferred embodiment, the antibody is anti-IgE and the target molecule is IgE. In another embodiment, the invention relates to an anti-IgE antibody having improved affinity to IgE.
    • 本发明涉及通过以下步骤的组合来调节多肽与靶分子的亲和力的方法,包括:(1)鉴定易于异构化的天冬氨酰残基; (2)替代替代残基并筛选得到的突变体对靶分子的亲合力。 在优选的实施方案中,取代残基的方法是用噬菌体展示(AMPD)进行亲和力成熟。 在另一优选实施方案中,多肽是抗体,靶分子是抗原。 在另一个优选的实施方案中,抗体是抗IgE,靶分子是IgE。 在另一个实施方案中,本发明涉及对IgE具有改善的亲和力的抗IgE抗体。